Vanguard Group’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61.7M | Buy |
|
|||||
|
2025
Q1 | $70.2M | Sell |
|
|||||
|
2024
Q4 | $101M | Buy |
|
|||||
|
2024
Q3 | $132M | Buy |
|
|||||
|
2024
Q2 | $107M | Sell |
|
|||||
|
2024
Q1 | $120M | Sell |
|
|||||
|
2023
Q4 | $174M | Buy |
|
|||||
|
2023
Q3 | $127M | Sell |
|
|||||
|
2023
Q2 | $159M | Buy |
|
|||||
|
2023
Q1 | $99.4M | Buy |
|
|||||
|
2022
Q4 | $73.5M | Buy |
|
|||||
|
2022
Q3 | $73.2M | Buy |
|
|||||
|
2022
Q2 | $89.1M | Buy |
|
|||||
|
2022
Q1 | $89.1M | Buy |
|
|||||
|
2021
Q4 | $57.5M | Sell |
|
|||||
|
2021
Q3 | $48M | Buy |
|
|||||
|
2021
Q2 | $49.6M | Sell |
|
|||||
|
2021
Q1 | $46.8M | Buy |
|
|||||
|
2020
Q4 | $49.8M | Buy |
|
|||||
|
2020
Q3 | $45.2M | Buy |
|
|||||
|
2020
Q2 | $53.7M | Buy |
|
|||||
|
2020
Q1 | $35.4M | Buy |
|
|||||
|
2019
Q4 | $45.6M | Sell |
|
|||||
|
2019
Q3 | $48.1M | Buy |
|
|||||
|
2019
Q2 | $50.3M | Buy |
|
|||||
|
2019
Q1 | $47.5M | Buy |
|
|||||
|
2018
Q4 | $45.5M | Buy |
|
|||||
|
2018
Q3 | $43.2M | Sell |
|
|||||
|
2018
Q2 | $34.6M | Sell |
|
|||||
|
2018
Q1 | $43.7M | Buy |
|
|||||
|
2017
Q4 | $44M | Sell |
|
|||||
|
2017
Q3 | $42.7M | Sell |
|
|||||
|
2017
Q2 | $43.1M | Buy |
|
|||||
|
2017
Q1 | $31.6M | Buy |
|
|||||
|
2016
Q4 | $40M | Buy |
|
|||||
|
2016
Q3 | $34.7M | Buy |
|
|||||
|
2016
Q2 | $24.2M | Buy |
|
|||||
|
2016
Q1 | $17.2M | Buy |
|
|||||
|
2015
Q4 | $18M | Buy |
|
|||||
|
2015
Q3 | $13.6M | Buy |
|
|||||
|
2015
Q2 | $17.9M | Buy |
|
|||||
|
2015
Q1 | $12.8M | Buy |
|
|||||
|
2014
Q4 | $1.81M | Buy |
|
|||||
|
2014
Q3 | $568K | Buy |
|